Pharmafile Logo
Pharmafocus logo
Advanced Search

Novo Nordisk

Showing 15 posts of 177 posts found.

jakob-riis

Novo Nordisk’s Head of North America resigns

March 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment

Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …

News
roche_close

Death in trial of Roche’s potential blockbuster haemophilia drug

February 24, 2017
Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia

Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …

News
insulin-syringe-1972843_960_720

Price-fixing class action lawsuit levelled at three major insulin producers

January 31, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing

A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …

News
novo_flag

Novo Nordisk launches £115 million investment in UK despite Brexit

January 30, 2017
Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit

Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …

News
novo_nordisk_flag

Novo strikes up personalised diabetes treatment deal with Glooko

January 16, 2017
Sales and Marketing Glooko, Novo Nordisk, ibm

Novo Nordisk has entered into a partnership with Californian firm Glooko to develop a number of offerings to aid with …

News

Sanofi files lawsuit against Novo Nordisk over ‘false allegations’

January 3, 2017
Manufacturing and Production, Sales and Marketing Novo Nordisk, Sanofi

Sanofi has sued Novo Nordisk over claims made in an advertising campaign for its drug Tresiba. Sanofi has filed the …

News
novonordiskhq

Fluor wins $2 billion Novo contract to build API manufacturing facility

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fluor, Novo Nordisk, north carolina

Fluor Corporation has won an engineering, procurement and construction management contract for Novo Nordisk’s $2 billion diabetes active pharmaceutical ingredient …

News
jakob-riis

Novo pledges single-digit cap on drug price hikes

December 7, 2016
Medical Communications, Research and Development, Sales and Marketing Jakob Riis, Novo Nordisk

Novo Nordisk US chief Jakob Riis (pictured) has announced the insulin giant’s commitment to limit its price increases to single-digit …

News

Ablynx secures first €1m milestone payment from Novo Nordisk

December 5, 2016
Sales and Marketing Ablynx, Novo Nordisk, nanobody

Ablynx has secured €1 million from Novo Nordisk as it hits its first discovery milestone for its multi-specific nanobody construct, …

News
fdaoutsideweb

Sanofi and Novo to face off in diabetes sphere following FDA approvals

November 22, 2016
Manufacturing and Production, Sales and Marketing FDA, Novo Nordisk, Sanofi, Soliqua, Xultophy, diabetes

Sanofi and Novo are set to face off in the diabetes market after the FDA approved combination treatments from the …

News
novonordisk

Novo Nordisk to cut 2% of its entire workforce

September 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses

Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …

News
novo_nordisk_flag

Novo Nordisk to provide discounted insulin to poorest nations

September 23, 2016
Medical Communications, Sales and Marketing Novo Nordisk, diabetes, insulin

Danish pharma firm Novo Nordisk has announced its intention to provide insulin at discounted prices to the world’s poorest nations …

News
novo_corp_hq2

Novo Nordisk’s diabetes drug “significantly reduced’ cardiovascular risk

September 16, 2016
Medical Communications Novo Nordisk, diabetes, semaglutide

Novo Nordisk has announced that its diabetes drug semaglutide “significantly reduced” the risk of major cardiovascular events at the 52nd …

News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

September 9, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, BMS, Celgene, Cloud Computing, Eisai, FDA, GSK, Halaven, Novartis, Novo Nordisk, Roche, Teva, agios, epipen, rheumatoid arthritis

It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …

News

Lars Rebien Sørensen to retire as CEO of Novo Nordisk

September 1, 2016
Novo Nordisk, appointment

Novo Nordisk has announced that its president and CEO Lars Rebian Sørensen (pictured) is to retire at the end of …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023